HYLS1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.128000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.516800E-01
Normal-vs-Stage2
6.485000E-01
Normal-vs-Stage3
7.482600E-01
Normal-vs-Stage4
7.759600E-01
Stage1-vs-Stage2
2.969000E-01
Stage1-vs-Stage3
2.831200E-01
Stage1-vs-Stage4
6.888400E-01
Stage2-vs-Stage3
3.280600E-01
Stage2-vs-Stage4
9.341200E-01
Stage3-vs-Stage4
5.896000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.276400E-01
Normal-vs-AfricanAmerican
4.770800E-01
Normal-vs-Asian
6.449000E-01
Caucasian-vs-AfricanAmerican
7.368000E-01
Caucasian-vs-Asian
8.373200E-01
AfricanAmerican-vs-Asian
8.939800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.510200E-01
Normal-vs-Female
5.754400E-01
Male-vs-Female
6.746600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.960800E-01
Normal-vs-Age(41-60Yrs)
4.541600E-01
Normal-vs-Age(61-80Yrs)
6.572600E-01
Normal-vs-Age(81-100Yrs)
8.647200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.216600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.119000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.357200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.054000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.918000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.822400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.908400E-01
Normal-vs-Daily Drinker
8.235800E-01
Normal-vs-Weekly Drinker
5.503000E-01
Normal-vs-Occasional Drinker
8.312000E-01
Normal-vs-Social Drinker
4.703400E-01
Non Drinker-vs-Daily Drinker
5.682600E-01
Non Drinker-vs-Weekly Drinker
1.891820E-01
Non Drinker-vs-Occasional Drinker
6.149000E-01
Non Drinker-vs-Social Drinker
9.638200E-02
Daily Drinker-vs-Weekly Drinker
5.303200E-01
Daily Drinker-vs-Occasional Drinker
9.525400E-01
Daily Drinker-vs-Social Drinker
3.543800E-01
Weekly Drinker-vs-Occasional Drinker
4.832400E-01
Weekly Drinker-vs-Social Drinker
7.734000E-01
Occasional Drinker-vs-Social Drinker
3.199600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.369600E-01
Normal-vs-Grade 2
8.103600E-01
Normal-vs-Grade 3
8.256200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.881800E-01
Grade 1-vs-Grade 3
8.804600E-01
Grade 1-vs-Grade 4
8.369600E-01
Grade 2-vs-Grade 3
7.999000E-01
Grade 2-vs-Grade 4
8.103600E-01
Grade 3-vs-Grade 4
8.256200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.683800E-01
Normal-vs-NonDiabetic
5.491200E-01
Diabetic-vs-NonDiabetic
4.630500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.328000E-01
Normal-vs-NoPancreatitis
6.810400E-01
Pancreatitis-vs-NoPancreatitis
4.552200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.887000E-01
Normal-vs-N1
6.488200E-01
N0-vs-N1
3.282400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.318600E-01
Normal-vs-TP53-NonMutant
3.280000E-01
TP53-Mutant-vs-TP53-NonMutant
6.580600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
